U.S. Markets open in 3 hrs 18 mins

SPDR S&P MidCap 400 ETF (MDY)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
321.22+0.86 (+0.27%)
At close: 4:00PM EDT
People also watch
IJRIWMDIAXLBXLI
Full screen
Previous Close320.33
Open319.84
Bid320.50 x 2000
Ask321.28 x 2000
Day's Range319.87 - 321.49
52 Week Range268.25 - 326.88
Volume894,789
Avg. Volume1,076,623
Net Assets18B
NAV315.62
PE Ratio (TTM)N/A
Yield1.15%
YTD Return5.04%
Beta (3y)0.97
Expense Ratio (net)0.25%
Inception Date1995-05-04
Trade prices are not sourced from all markets
  • ETF.com14 days ago

    Least Popular ETFs Of The Year

    It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.

  • Market Realist19 days ago

    How Are Bioverativ’s Key Drugs Positioned after 2Q17?

    In 2Q17, Bioverativ’s Alprolix generated revenues of ~$89.7 million, which represents ~12% growth YoY (year-over-year) and ~4% growth sequentially.

  • Market Realist25 days ago

    How Did United Therapeutics’ Orenitram and Unituxin Perform in 2Q17?

    In 2Q17, United Therapeutics’ (UTHR) Unituxin generated revenues of around $16 million, a 10% decline on a year-over-year (or YoY) basis and an 11% decline on a quarter-over-quarter basis.